Home » DYNAVAX FILES $75 MLN STOCK SHELF
DYNAVAX FILES $75 MLN STOCK SHELF
Drug maker Dynavax Technologies Corp. (DVAX.O: Quote, Profile, Research) may periodically sell up to $75 million in common stock according to a regulatory filing on Monday. The Berkeley, California-based company said it plans to use the proceeds for general corporate purposes research and development and acquisitions, according to the filing with the U.S. Securities and Exchange Commission. Under a shelf registration, a company may sell securities in one or more separate offerings with the size, price and terms to be determined at the time of the sale.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May